NM_000543.5:c.509G>A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000543.5(SMPD1):c.509G>A(p.Trp170*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000685 in 1,460,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000543.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460652Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 726548
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Niemann-Pick disease, type A Pathogenic:2
- -
- -
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SMPD1 are known to be pathogenic (PMID: 12369017, 15221801). This variant has been observed to be homozygous in an individual affected with Niemann-Pick type A (PMID: 19405096). This variant is also known as p.W168X in the literature. ClinVar contains an entry for this variant (Variation ID: 529233). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp170*) in the SMPD1 gene. It is expected to result in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at